Arunjyoti Bio Ventures Share Price in Focus as Company Returns to Profit in Q1 FY27
- July 10, 2026
- Posted by: Kashish Aggarwal
- Category: News
Arunjyoti Bio Ventures Q1 FY27 net profit Rs 61.24 lakh, reversing Rs 540.09 lakh loss in Q4 FY26. Revenue Rs 820 lakh, up from Rs 723.73 lakh. Board approves name change to Pasura Industries.
The Arunjyoti Bio Ventures share price is in focus after the company reported a return to profitability in its Q1 FY27 results, announced on 9 July 2026. The company posted a net profit of Rs 61.24 lakh for the quarter, a sharp turnaround from a net loss of Rs 540.09 lakh in the preceding March 2026 quarter, and the board also approved a proposal to change the company’s name.
Click Here – Get Free Investment Predictions
Arunjyoti Bio Ventures Q1 FY27 Results: Key Numbers
| Metric | Q1 FY27 | Q4 FY26 |
|---|---|---|
| Net profit / (loss) | Rs 61.24 lakh (profit) | Rs 540.09 lakh (loss) |
| Revenue from operations | Rs 820.00 lakh | Rs 723.73 lakh |
Get Small-Cap Stock Guidance from SEBI Registered Investment Advisors
A Sharp Turnaround Behind the Arunjyoti Bio Ventures Share Price
The headline development behind today’s Arunjyoti Bio Ventures share price focus is the scale of the swing between quarters: from a net loss of Rs 540.09 lakh in the March 2026 quarter to a net profit of Rs 61.24 lakh in the June 2026 quarter. This kind of sharp turnaround, alongside revenue growth from Rs 723.73 lakh to Rs 820.00 lakh, suggests the company’s operations stabilised meaningfully during the quarter, though investors should note that a single quarter’s turnaround does not necessarily confirm a durable trend, particularly for a smaller company where results can be more volatile.
Board Approves Proposed Name Change, a Factor for the Arunjyoti Bio Ventures Share Price
Alongside the results, the Arunjyoti Bio Ventures board approved a proposal to change the company’s name to Pasura Industries Limited, a change that remains subject to shareholder approval before it can formally take effect. Name changes of this nature can sometimes accompany a broader shift in business focus or strategic repositioning, and investors tracking the Arunjyoti Bio Ventures share price should watch for further disclosure on the rationale behind this proposed change as the shareholder approval process unfolds.
Other Governance Decisions Affecting the Arunjyoti Bio Ventures Share Price
The board also addressed a governance matter, waiving recovery of an aggregate excess managerial remuneration of Rs 25.19 lakh that had been paid to whole-time directors Pabbathi Badhri Narayana Murthy and Nadimpalli Vishal for FY26, alongside revising the remuneration structure for whole-time directors going forward. Both decisions affecting the Arunjyoti Bio Ventures share price require shareholder approval, expected to be addressed at the company’s 40th Annual General Meeting scheduled for 12 August 2026, a date also relevant for the Arunjyoti Bio Ventures share price. Separately, the company’s secretarial auditor resigned effective 9 July 2026, with a new firm appointed to fill the vacancy.
About the Business Behind the Arunjyoti Bio Ventures Share Price
Arunjyoti Bio Ventures has positioned itself within the contract manufacturing or co-packing space for consumer food products, having installed a jelly pouch production line in Jangaon, Telangana for Tata Consumer Products, with commercial production of 5-pack jelly pouches beginning in March 2026. This kind of co-packing relationship supporting the Arunjyoti Bio Ventures share price with a large, established consumer products company can provide a degree of revenue visibility, though the company’s overall scale remains small based on its quarterly revenue figures relative to the broader Arunjyoti Bio Ventures share price story.
What Investors Should Watch Next for the Arunjyoti Bio Ventures Share Price
Investors tracking the Arunjyoti Bio Ventures share price should watch whether the return to profitability seen in Q1 FY27 can be sustained in coming quarters, the progress of the proposed name change to Pasura Industries Limited through the shareholder approval process, and the pace at which the company’s co-packing operations for consumer product clients like Tata Consumer Products scale up over time.
Download the Univest iOS App or Univest Android App to track the Arunjyoti Bio Ventures share price and Q1 FY27 earnings updates live.
Conclusion
The Arunjyoti Bio Ventures share price is in focus today following a sharp turnaround to profitability in Q1 FY27, alongside a board-approved proposal to rename the company to Pasura Industries Limited. Investors should watch upcoming quarters and the shareholder approval process for these governance changes to assess whether this quarter’s improvement reflects a sustainable trend.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions FAQs
Why is the Arunjyoti Bio Ventures share price in focus today?
Ans. The Arunjyoti Bio Ventures share price is in focus after the company reported a net profit of Rs 61.24 lakh for Q1 FY27, a sharp turnaround from a net loss of Rs 540.09 lakh in the preceding March 2026 quarter, alongside a board-approved proposal to change the company’s name.
What were the key highlights of Arunjyoti Bio Ventures’ Q1 FY27 results?
Ans. The company reported a net profit of Rs 61.24 lakh for the quarter ended 30 June 2026, reversing a net loss of Rs 540.09 lakh in the prior quarter, with revenue from operations of Rs 820.00 lakh, up from Rs 723.73 lakh in the preceding quarter.
What name change did Arunjyoti Bio Ventures’ board approve?
Ans. The board approved a proposal to change the company’s name from Arunjyoti Bio Ventures Limited to Pasura Industries Limited, a change that remains subject to shareholder approval before it can take effect.
What other decisions did the Arunjyoti Bio Ventures board make alongside the results?
Ans. The board also waived recovery of an aggregate excess managerial remuneration of Rs 25.19 lakh that had been paid to two whole-time directors for FY26, and revised the remuneration structure for its whole-time directors going forward, both changes also subject to shareholder approval.
What does Arunjyoti Bio Ventures manufacture?
Ans. Arunjyoti Bio Ventures has installed a jelly pouch production line in Jangaon, Telangana for Tata Consumer Products, with commercial production of 5-pack jelly pouches beginning in March 2026, positioning the company within the contract manufacturing or co-packing space for consumer food products.
What should investors watch for Arunjyoti Bio Ventures going forward?
Ans. Investors should watch whether the return to profitability in Q1 FY27 can be sustained in coming quarters, the progress of the proposed name change to Pasura Industries Limited through the shareholder approval process, and the scale-up of the company’s co-packing operations for consumer product clients.
